CRISIL Ltd
BSE:500092

Watchlist Manager
CRISIL Ltd Logo
CRISIL Ltd
BSE:500092
Watchlist
Price: 4 460.6499 INR 3.14% Market Closed
Market Cap: 326.2B INR

CRISIL Ltd
Investor Relations

In the bustling milieu of global finance, CRISIL Ltd. stands as a venerable beacon of analytical acumen and market intelligence. Born in India yet globally revered, CRISIL, which initially made its mark through credit ratings, has woven a rich tapestry of services across varied financial landscapes. The core of its strength lies in its proficiency in assessing the creditworthiness of a vast array of entities, ranging from large corporations to intricate structured finance products. By meticulously evaluating the financial health and risk profiles of these entities, CRISIL furnishes investors and stakeholders with the critical insights they require to make informed decisions. This process of rating not only fortifies the trust in financial markets but also underpins the very foundation of investment strategies for institutions and individuals alike.

Beyond credit ratings, CRISIL monetizes its intellectual capital by offering an extensive repertoire of research services and analytics. The company's consulting services are integral, as they assist firms globally in navigating complex regulatory frameworks and optimizing their financial strategies. Through data-driven insights and rigorous market analysis, CRISIL supports clients across sectors, from banking and insurance to infrastructure and technology. Moreover, its foray into data and research subscriptions allows it to delve deeper into the nuances of market behavior and economic trends, offering a rich source of recurring revenue. In essence, CRISIL capitalizes on its decades-long heritage of financial expertise, leveraging its formidable analytical prowess to not only sustain but strategically grow its business amidst the ever-evolving dynamics of the global financial ecosystem.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2025
Call Date
May 6, 2025
AI Summary
Q1 2025

Strong Q1 Growth: Crisil reported a 10.2% increase in revenue and about 16% growth in profit before tax and profit after tax for Q1 FY25, driven by robust performance in Ratings and improved margins.

Ratings Outperformance: The Ratings Services segment grew by approximately 32.5% year-on-year in Q1 2025, significantly outperforming industry growth, due to strong demand for high-quality ratings and several large deals.

Global Uncertainty: Management highlighted ongoing global macroeconomic uncertainty, including tariff actions and slower GDP forecasts, but noted resilience across core business areas.

Research Segment Challenges: Research Analytics and Solutions segment saw muted growth due to curtailed discretionary spending by global clients, but margins improved through cost control.

GenAI Adoption: Company is actively investing in and deploying GenAI solutions in both internal processes and client offerings, with early successes in credit assessment and analytics products.

Positive Domestic Outlook: India's GDP is projected to grow at 6.5% in fiscal 2026, with expected tailwinds for bank credit and corporate bond issuances due to policy support and potential rate cuts.

No Forward Guidance: Crisil refrained from providing specific quantitative guidance or disclosing segment-level operational details.

Key Financials
Dividend
INR 8 (first interim dividend)
Bond Issuances Growth
3.9% YoY in Q1 2025
Bank Credit Growth
11% as on February 2025
Wholesale Bank Credit Growth
9.8% as on February 2025
Large Corporate Credit Growth
5.2% as on February 2025
Gross Non-Performing Assets
2.5% to 2.6% of advances
Mutual Fund AUM as % of GDP
18.2% in fiscal 2024
India GDP Growth (Outlook)
6.5% in fiscal 2026 (expected)
Bank Credit Growth (Forecast)
12% to 13% for current fiscal
Earnings Call Recording
Other Earnings Calls
2025

Management

Mr. Amish P. Mehta
MD, CEO & Director
No Bio Available
Mr. Sanjay Chakravarti B.Com, C.A.
President of Risk and Compliance
No Bio Available
Ms. Minal Amit Bhosale
Compliance Officer & Company Secretary
No Bio Available
Mr. Andries Petrus Cronje
President & Head of International Business
No Bio Available
Mr. Jan Larsen
President and Head of CRISIL Global Research & Risk Solutions
No Bio Available
Mr. Duncan McCredie
President & Head of Global Benchmarking Analytics
No Bio Available
Ms. Pooja Mirchandani
President & Chief Human Resources Officer
No Bio Available
Mr. Dinesh Venkatasubramanian
Chief Financial Officer
No Bio Available
Mr. Gurpreet S. Chhatwal
Chief Operating Officer
No Bio Available
Mr. Zak Murad
Chief Technology & Information Officer
No Bio Available

Contacts

Address
MAHARASHTRA
Mumbai
Crisil House, Central Avenue, Hiranandani Business Park, Powai
Contacts
+912233423000
www.crisil.com